Search

COVID-19 has taught us a lot about minimizing our risk and focusing on wellness and prevention in our lives. Anita and John dig into what this shift means to the dietary supplements category of the consumer healthcare industry.

During this episode, get a behind-the-scenes look at CHPA’s policy priorities and the role that the new Congress plays in shaping healthcare from CHPA’s Federal Government Affairs Vice President Marc Schloss and Director Taylor Holgate.

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

What follows is a timeline for implementation of OTC monograph reform under HR 748, also known as the CARES Act.

Despite the challenges of COVID-19 in 2020, CHPA remained hard at work on behalf of its members.

Find detailed information about each section of the CARES Act, which was passed in 2020 in response to the COVID-19 pandemic.

CHPA, its educational foundation, and member companies are empowering consumers to practice responsible self-care, providing resources to help respond to this pandemic. We’re guided by these core principles.

CHPA continues to monitor state and local orders for healthcare-related workforce and logistics disruptions as they are announced.

CHPA continues to closely monitor the rapidly-evolving Coronavirus Disease 2019 (COVID-19) outbreak.